Literature DB >> 9264490

Changes in phasic coronary blood flow velocity profile and relative coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy.

M K Kyriakidis1, J M Dernellis, A E Androulakis, G A Kelepeshis, J Barbetseas, A N Anastasakis, A G Trikas, C A Tentolouris, J E Gialafos, P K Toutouzas.   

Abstract

BACKGROUND: In this study, we both investigated coronary flow velocity in hypertrophic obstructive cardiomyopathy (HOCM) and tested the hypothesis of differing coronary flow reserve (CFR) of coronary arteries perfusing left ventricular regions with nonuniform myocardial hypertrophy by measuring the relative CFR. METHODS AND
RESULTS: Coronary flow velocity was assessed in left anterior descending coronary (LAD) and left circumflex (LCX) arteries in 18 patients with HOCM and marked hypertrophy only in the ventricular septum, in 13 patients without obstruction (HCM), and in 9 age- and sex-matched normal subjects at rest, during rapid atrial pacing, and after dobutamine infusion (5 to 30 microg/kg per minute). Relative CFR was estimated as the ratio between absolute CFR of the LAD and absolute CFR of the LCX (LAD/LCX(CF)). At the peak of rapid atrial pacing and during dobutamine stress, LAD/LCX(CF) was reversed in HOCM patients (from 1.25+/-0.11 to 0.82+/-0.07 and 0.79+/-0.06, respectively), whereas it remained unchanged in control subjects (from 1.0+/-0.1 to 1.0+/-0.05 and 1.0+/-0.05, respectively; P<.001). In HCM patients, LAD/LCX(CF) at rest was 1.10+/-0.11, whereas during rapid atrial pacing and dobutamine stress, it was 0.92+/-0.08 and 0.90+/-0.09, respectively. Relative CFR was 0.62+/-0.05 in HOCM patients and 1.05+/-0.05 (P<.001) in normal subjects. There was an inverse correlation between relative CFR and peak systolic outflow tract gradient (r2=.74, P<.001).
CONCLUSIONS: Regional distribution of hypertrophy in some patients with HOCM resulted in regional impairment of coronary flow. Relative CFR can be used to estimate regional disturbances of coronary flow and may help in patient selection for new interventional therapeutic techniques.

Entities:  

Mesh:

Year:  1997        PMID: 9264490     DOI: 10.1161/01.cir.96.3.834

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Systolic compression of anomalous large septal branch: an unusual cause of myocardial ischemia.

Authors:  Remzi Yilmaz; Recep Demirbag
Journal:  Int J Cardiovasc Imaging       Date:  2005-10       Impact factor: 2.357

2.  Coronary flow velocity changes in response to hypercapnia: assessment by transthoracic Doppler echocardiography.

Authors:  Wendy S Tzou; Claudia E Korcarz; Susan E Aeschlimann; Barbara J Morgan; James B Skatrud; James H Stein
Journal:  J Am Soc Echocardiogr       Date:  2007-04       Impact factor: 5.251

3.  Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics.

Authors:  M J Kofflard; M Michels; R Krams; M Kliffen; M L Geleijnse; F J Ten Cate; P W Serruys
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

4.  Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy.

Authors:  Saidi A Mohiddin; Lameh Fananapazir
Journal:  Tex Heart Inst J       Date:  2002

5.  Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Tai Sekine; Masao Daimon; Rei Hasegawa; Kiyomi Teramoto; Takayuki Kawata; Nobuhiro Tanaka; Yasuhiro Takei; Kenji Takazawa; Katsuya Yoshida; Issei Komuro
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

6.  Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy.

Authors:  P Petkow Dimitrow; M Krzanowski; R Nizankowski; A Szczeklik; J S Dubiel
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

7.  Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  James M Wilson; Rollo P Villareal; Ramesh Hariharan; Ali Massumi; Raja Muthupillai; Scott D Flamm
Journal:  Tex Heart Inst J       Date:  2002

8.  Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.

Authors:  Claire E Raphael; Robert Cooper; Kim H Parker; Julian Collinson; Vassilis Vassiliou; Dudley J Pennell; Ranil de Silva; Li Yueh Hsu; Anders M Greve; Sukh Nijjer; Chris Broyd; Aamir Ali; Jennifer Keegan; Darrel P Francis; Justin E Davies; Alun D Hughes; Andrew Arai; Michael Frenneaux; Rod H Stables; Carlo Di Mario; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2016-10-11       Impact factor: 24.094

9.  Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy.

Authors:  Paola Roldan; Sriram Ravi; James Hodovan; J Todd Belcik; Stephen B Heitner; Ahmad Masri; Jonathan R Lindner
Journal:  Cardiovasc Ultrasound       Date:  2022-09-19       Impact factor: 2.263

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.